ARX vs GSHD: Which Is the Better Buy in 2026?
Last updated November 2026
Short answer
ARX is the larger of the two ($4.32B market cap): the incumbent the market prices for continued execution (21.22x forward earnings). GSHD is the smaller challenger ($1.66B), cheaper on forward earnings (17.72x): more room to run, but more to prove. The real question is which set of drivers you believe, and whether owning one (or both) leaves you over-concentrated.
ARX vs GSHD: the tie-breaker metrics
Same yardstick, side by side (as of November 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.
| Metric | ARX | GSHD | What it tells you |
|---|---|---|---|
| Market cap | $4.32B | $1.66B | Size. The larger name is the incumbent; the smaller has more room to grow and more to prove. |
| Forward P/E | 21.22 | 17.72 | Valuation on next year's expected earnings, the same yardstick for both. Lower is cheaper for that growth; higher means the market is paying up. |
| Price vs 52-week range | 100% of range | 28% of range | Where today's price sits between the 52-week low and high. Near the high is momentum with less margin of safety; near the low is out of favor or a discount, depending on why. |
Reading it: GSHD is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.
Before you buy: how ARX and GSHD affect your concentration
The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. ARX and GSHD share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.
This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined ARX and GSHD exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.
What does Accelerant Holdings (ARX) do?
Accelerant Holdings operates a data-driven risk exchange for specialty insurance. On one side are managing general agents (MGAs), the specialist underwriters who design and sell niche insurance products; on the other are risk capital partners such as insurers, reinsurers, and institutional investors who put up the capital to back those policies. Accelerant sits in the middle, using proprietary technology, data, and machine learning to match risk with capital, share high-fidelity underwriting data, and monitor portfolios. It earns a fixed-percentage, volume-based fee for sourcing, managing, and monitoring the business written through the exchange, which spans more than 500 specialty insurance products across 22 countries. The company reports through three segments: Exchange Services, MGA Operations, and Underwriting, and describes its model as capital-light because it aims to retain only a small share of the premium risk (roughly 9% in 2025) and pass the rest to third-party capital.
What does Goosehead Insurance (GSHD) do?
Goosehead Insurance, founded in 2003 in Westlake, Texas by Mark and Robyn Jones, is an independent personal-lines insurance agency. It places homeowners, auto, flood, and umbrella policies with a panel of carriers and collects a commission, so it never puts capital behind a claim. It runs two channels. The Corporate Channel employs its own agents and is the training ground and proof of concept. The Franchise Channel is the scale engine: franchisees pay an initial fee and then split commissions with Goosehead, keeping the large majority of new business commissions but only about half of renewal commissions. That split is the whole economic story, because a franchise that has been operating for several years throws off renewal royalties on a book Goosehead did not have to staff. A large share of new business arrives through referral partners, particularly real estate agents and mortgage originators at the point of home purchase.
ARX vs GSHD: how do they differ?
Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.
- ARX drivers: The Thoma Bravo deal sets the price; Go-shop ended with no rival bid.
- GSHD drivers: Renewal royalties compounding on an aging franchise book; Producer growth, weighted toward the corporate channel.
Which fits which kind of investor
A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. A useful test is which set of risks you could hold through a drawdown: With a signed all-cash agreement, the main risk is deal completion. For GSHD, the valuation is the first-order risk: roughly 33x trailing earnings on an ~8.8% net margin (as of October 16, 2026) leaves the stock dependent on growth staying well above the industry rate, and small-cap distribution stocks derate quickly when it does not, as the roughly 34.5% decline in 2026 shows.
ARX or GSHD: which should you pick?
Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick ARX if you believe its drivers more; GSHD if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the ARX and GSHD guides.
ARX vs GSHD: the full fundamentals
ARX. Since August 13, 2026 ARX has been valued by the Thoma Bravo offer, not by earnings multiples. At $19.75 the shares trade about 2.5% below the $20.25 cash price, a spread that reflects the time until the expected first-half 2027 close and the chance the deal does not complete. Measures such as about 4 times TTM sales or 21 times forward earnings describe what the buyer is paying rather than where the stock is likely to trade before closing.
GSHD. Figures are approximate and tied to the asOf date; verify live numbers before acting. After falling roughly 34.5% in 2026, Goosehead trades near 33x trailing and 17x forward earnings, still above the US insurance industry's typical multiple because the market treats it as a distribution compounder rather than a carrier, though comparisons to Progressive or Allstate on P/E are not meaningful given Goosehead takes no underwriting risk. Analysts expect EPS of about $2.10 in 2026 and $2.63 in 2027; the 12 in Yahoo's consensus average a buy with a mean target near $62, though October target cuts from Piper Sandler, Truist and BofA sit between $42 and $48. Note also that the Up-C structure means reported EPS reflects only the Class A economic interest, so headline market cap and headline EPS are not measuring the same denominator.
Headline figures (approximate, October 2026): ARX shows deal price (thoma bravo, all cash) $20.25 per share; enterprise value >$4 billion, share price / spread to deal $19.75 (Oct 16, 2026) / ~2.5%, expected close First half of 2027, revenue (ttm) ~$1.07 billion; GSHD shows revenue (ttm) ~$401.6 million (Q2 2026 ~+21% YoY), revenue (q2 2026) ~$113.4 million (core revenue ~$95.6 million, up ~10%), net income (ttm) ~$35.3 million, a net margin near 8.8%, q2 2026 eps vs estimate ~$0.64 vs ~$0.48.
The bottom line: ARX vs GSHD
ARX and GSHD are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined ARX and GSHD exposure against your real portfolio. It is not an investment adviser.
Wondering how ARX or GSHD fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.
Your questions about Accelerant Holdings
Ask Walnut's AI anything about ARX and see how it fits what you own.
FAQ
What is the difference between ARX and GSHD?
+
Accelerant Holdings operates a data-driven risk exchange for specialty insurance. Goosehead Insurance, founded in 2003 in Westlake, Texas by Mark and Robyn Jones, is an independent personal-lines insurance agency. They show up together because they share investment themes, but they are different businesses, so the better fit depends on which thesis you are expressing.
Is ARX or GSHD the better stock?
+
Neither is universally better. ARX is the larger incumbent; GSHD is the smaller challenger and looks cheaper on forward earnings. Walnut is informational, not investment advice. Compare what each does, the tie-breaker metrics above, and the risks, then decide which fits your thesis and what you already own.
Which is cheaper, ARX or GSHD?
+
On forward P/E (as of November 2026), ARX trades at 21.22x and GSHD at 17.72x, so GSHD is the cheaper of the two on next year's expected earnings. A lower multiple is not automatically the better buy: a richer valuation can be justified by faster growth, and a lower one can reflect real risk. Weigh the multiple against how fast each business is compounding.
Should you own both ARX and GSHD?
+
Because they share themes, owning both concentrates you in that theme. That can be intentional (a focused bet) or accidental (less diversification than it looks). Walnut can show your combined exposure across both, and whether adding either over-concentrates you, before you buy.
What are the risks of ARX vs GSHD?
+
ARX: With a signed all-cash agreement, the main risk is deal completion. Shareholder approval, regulatory approvals for an insurance business, financing and other conditions could delay or block the transaction, and the expected close in the first half of 2027 leaves months for something to change. If the deal failed, the stock would likely fall back toward a price set by fundamentals; it traded near $13 in July 2026, before the announcement-day jump of about 43%. The upside is capped near $20.25 unless a higher bid appears, and the go-shop ended without one. Holders also bear the time value of waiting: a roughly 2.5% spread over several months is a modest return for that risk. The underlying business risks still apply to a broken-deal scenario: a capital-light model unproven across a full insurance cycle, dependence on keeping MGAs and capital partners engaged, a large reported net loss tied to the IPO, and cyclical specialty insurance pricing. GSHD: The valuation is the first-order risk: roughly 33x trailing earnings on an ~8.8% net margin (as of October 16, 2026) leaves the stock dependent on growth staying well above the industry rate, and small-cap distribution stocks derate quickly when it does not, as the roughly 34.5% decline in 2026 shows. The balance sheet carries about $373 million of debt against roughly $24 million of cash, and several brokers downgraded the shares or cut targets in October 2026. The homeowners hard market is a double-edged input, because rate increases lift commissions today but carrier appetite has tightened in Texas, Florida, and California, and a softening market would slow premium growth without any operational failure. Contingent commissions, which are carrier profit-sharing payments outside core revenue, drove much of the gap between ~21% total and ~10% core revenue growth in Q2 2026 and are not reliable year to year. New business is tied to home purchase activity through referral partners, so mortgage rates and existing home sales are exogenous drivers of a company-specific line. Governance carries the usual founder-controlled features of an Up-C structure with Class A and Class B shares, and the CEO transition at year end 2026 adds execution uncertainty. Goosehead also disclosed a March 2025 network intrusion where customer notification did not go out until October, which has drawn consumer litigation.
Walnut is informational, not investment advice. This page is descriptive and not a recommendation to buy or sell ARX or GSHD; figures are approximate and dated (as of November 2026). Verify current data before investing.